Zhenlong Yu Selected Research

Zhenlong Yu Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 01/2014
5	Lung Neoplasms (Lung Cancer) 11/2016 - 08/2014
4	Carcinogenesis 01/2019 - 10/2014
3	Glioblastoma (Glioblastoma Multiforme) 09/2020 - 01/2017
2	Tuberculosis (Tuberculoses) 07/2022 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 09/2018
2	Glioma (Gliomas) 01/2021 - 01/2017
2	Inflammation (Inflammations) 09/2019 - 01/2019
2	Pathologic Processes 01/2019 - 01/2018
2	Adenocarcinoma of Lung 12/2016 - 10/2014
1	Colitis 11/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Infections 10/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 06/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Nephritis 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Ulcerative Colitis 09/2019
1	Dental Caries (Decay, Dental) 03/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Acute Lung Injury 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2014
7	Biological ProductsIBA 11/2022 - 01/2016
7	LactonesIBA 01/2021 - 01/2017
6	SesquiterpenesIBA 11/2022 - 01/2017
4	MelatoninIBA 08/2018 - 01/2014
4	gamabufotalinIBA 11/2016 - 08/2014
3	DiterpenesIBA 01/2021 - 01/2018
3	EnzymesIBA 01/2019 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2017
3	chan su (ChanSu)IBA 11/2016 - 08/2014
2	Therapeutic UsesIBA 11/2022 - 05/2017
2	Dichlorodiphenyl Dichloroethylene (DDE)IBA 06/2021 - 01/2020
2	dehydrocostus lactoneIBA 01/2021 - 01/2017
2	alantolactoneIBA 09/2020 - 12/2017
2	LipopolysaccharidesIBA 09/2019 - 01/2019
2	Fluorescent Dyes (Fluorescent Probes)IBA 03/2019 - 01/2018
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019 - 08/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 10/2018 - 09/2018
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 10/2014
2	Small Interfering RNA (siRNA)IBA 12/2016 - 02/2016
2	bufadienolideIBA 11/2016 - 08/2014
2	Amphibian VenomsIBA 03/2016 - 08/2014
2	CaspasesIBA 02/2016 - 01/2016
2	Cytochromes c (Cytochrome c)IBA 02/2016 - 01/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	icariinIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 10/2021
1	Leucyl Aminopeptidase (Peptidase S)IBA 10/2021
1	3-methyladenineIBA 06/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	piperineIBA 01/2021
1	scutellarinIBA 01/2020
1	AldehydesIBA 01/2020
1	Dextrans (Dextran)FDA Link 09/2019
1	PowdersIBA 09/2019
1	SodiumIBA 09/2019
1	TeaIBA 03/2019
1	PolyphenolsIBA 03/2019
1	NaphthalimidesIBA 03/2019
1	GlucosyltransferasesIBA 03/2019
1	gambogic acidIBA 01/2019
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 01/2019
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2019
1	Catechin (Z 7300)IBA 01/2019
1	XenobioticsIBA 01/2019
1	procyanidin B1IBA 01/2019
1	andrographolideIBA 10/2018
1	Messenger RNA (mRNA)IBA 10/2018
1	nasIBA 08/2018
1	Antitubercular AgentsIBA 01/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2018
1	GlucuronidaseIBA 01/2018
1	Phosphotransferases (Kinase)IBA 12/2017
1	Glycoproteins (Glycoprotein)IBA 10/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	streptavidin-agaroseIBA 01/2017
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2017
1	Y-Box-Binding Protein 1IBA 12/2016
1	Caspase 3 (Caspase-3)IBA 12/2016

Therapy/Procedure

7	Therapeutics 10/2021 - 01/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 08/2018 - 01/2018
1	Oral Administration 09/2019
1	Ligation 01/2019
1	Aftercare (After-Treatment) 01/2017